Excerpt -----
“We’re delighted to see very strong support from the market,” Biotron boss Dr Michelle Miller told *.
The test results were “a major step to the ultimate goal of curing HIV-1 infection”, Dr Miller said.
But Biotron will need funding to progress to the next stage — and that means finding a partner if the biotech wants to avoid going back to the market for more cash.
DYOR
